Clinical Trial

A Study of DS3610a in Participants With Advanced Solid Tumor

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is designed to assess the safety, tolerability, and efficacy of DS3610a, given as a single agent to participants with advanced or metastatic solid tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-29; most recent amendment 2025-12-03.
Status change: Not Yet Recruiting → Recruiting 2025-11-21
Trial Details
NCT Number NCT07159126
Lead Sponsor Daiichi Sankyo
Conditions Solid Tumors, Metastatic Solid Tumors
Enrollment 70 participants
Start Date 2025-10-09
Primary Completion 2028-09-01 (estimated)
Study Completion 2031-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-10